New targets for antiviral therapies. The ability of dangerous viruses to cause lethal disease depends on their capacity to evade the immune system of infected hosts. This project will uncover at the molecular level the strategies used by viruses to disable immune responses; this will identify new ways to treat incurable diseases, by disabling the virus' defences against the immune system.
Linking immunomodulation and latency in alphaherpesvirus infection. Herpesviruses cause major diseases in humans and all domestic animal species. Latency forms a significant part of the evolutionary success of herpesviruses, by enabling transmission of the virus throughout the lifetime of the host. Our work has shown that an alphaherpesvirus protein can divert the host’s immune response to become more antibody-mediated and less T cell-mediated. This study explores the consequences of this immune ....Linking immunomodulation and latency in alphaherpesvirus infection. Herpesviruses cause major diseases in humans and all domestic animal species. Latency forms a significant part of the evolutionary success of herpesviruses, by enabling transmission of the virus throughout the lifetime of the host. Our work has shown that an alphaherpesvirus protein can divert the host’s immune response to become more antibody-mediated and less T cell-mediated. This study explores the consequences of this immune diversion, and examines whether this reduced T cell response enables the development of latent infections. Disrupting the virus-host balance by alterations to this conserved viral protein will enable novel approaches to controlling these economically significant viruses.Read moreRead less
Molecular approaches to limit herpesvirus recombination. This project aims to generate safer attenuated herpesvirus vaccines for use in veterinary medicine by genetically manipulating the herpesvirus genome to reduce virus recombination. Recombination is recognised as a safety concern for a range of attenuated herpesvirus vaccines. This project is expected to generate viruses that have an impaired capacity to recombine with other viruses. These viruses will then be tested as candidate vaccines f ....Molecular approaches to limit herpesvirus recombination. This project aims to generate safer attenuated herpesvirus vaccines for use in veterinary medicine by genetically manipulating the herpesvirus genome to reduce virus recombination. Recombination is recognised as a safety concern for a range of attenuated herpesvirus vaccines. This project is expected to generate viruses that have an impaired capacity to recombine with other viruses. These viruses will then be tested as candidate vaccines for use in veterinary medicine. This offers a new approach to developing safer veterinary vaccines that will benefit our important animal industries.Read moreRead less
Alphaherpesvirus recombination: safety implications for attenuated Herpesvirus vaccines. Under certain conditions some herpesviruses, including mild vaccine strains, can recombine to generate virulent viruses. Following findings that this occurred naturally between Australian poultry vaccines, with devastating results, this project will study natural herpesvirus recombination with the aim of allowing vaccines to be used more safely.
Imperfect vaccination drives herpesvirus evolution through recombination. Vaccines are used to help control disease caused by herpesviruses in animals, but some vaccination programs may drive the evolution and spread of herpesviruses with increased fitness (transmissibility, replication and virulence) through recombination. This project aims to study an important avian herpesvirus (infectious laryngotracheitis virus) in the natural host (poultry) to gain fundamental knowledge of how vaccination ....Imperfect vaccination drives herpesvirus evolution through recombination. Vaccines are used to help control disease caused by herpesviruses in animals, but some vaccination programs may drive the evolution and spread of herpesviruses with increased fitness (transmissibility, replication and virulence) through recombination. This project aims to study an important avian herpesvirus (infectious laryngotracheitis virus) in the natural host (poultry) to gain fundamental knowledge of how vaccination programs influence the emergence of diverse recombinant viruses, and identify which types of vaccination programs are best at preventing the emergence of fitter and more virulent viruses. The results are expected to inform vaccination practices to allow more effective control of these viruses in poultry and other animals.Read moreRead less
Virulence determinants influencing re-emergence of a complex RNA virus. This project intends to examine the effects that specific genes in naturally occurring recombinants have on their capacity to cause disease and spread between chickens. Coronaviruses are major pathogens of domestic animals throughout the world. Recurrent re-emergence of the coronavirus of chickens, infectious bronchitis virus, has been associated with recombination between wild type viruses and vaccine viruses, but the facto ....Virulence determinants influencing re-emergence of a complex RNA virus. This project intends to examine the effects that specific genes in naturally occurring recombinants have on their capacity to cause disease and spread between chickens. Coronaviruses are major pathogens of domestic animals throughout the world. Recurrent re-emergence of the coronavirus of chickens, infectious bronchitis virus, has been associated with recombination between wild type viruses and vaccine viruses, but the factors influencing this, and in particular the selective advantages genes from vaccine viruses confer on these recombinants, are unknown. The ultimate aim of the project is to identify both novel vaccines and alternative management strategies that might reduce the frequency of re-emergence of this virus and other coronaviruses.Read moreRead less
Harnessing innate immunity to mitigate bovine respiratory disease. Bovine Respiratory Disease (BRD) is the most significant health problem faced by the beef industry worldwide, causing economic losses of up to $40 million annually in Australia alone. This Project aims to assess an immunostimulant for its ability to induce resistance to infection with bovine respiratory viruses associated with BRD. The Project is expected to generate fundamental new knowledge in veterinary virology. Expected outc ....Harnessing innate immunity to mitigate bovine respiratory disease. Bovine Respiratory Disease (BRD) is the most significant health problem faced by the beef industry worldwide, causing economic losses of up to $40 million annually in Australia alone. This Project aims to assess an immunostimulant for its ability to induce resistance to infection with bovine respiratory viruses associated with BRD. The Project is expected to generate fundamental new knowledge in veterinary virology. Expected outcomes include scholarly publications. The Project will provide significant benefits, such as advances to fundamental knowledge, training of higher research degree students and proof-of-concept data to promote collaborations with commercial partners to develop novel treatment strategies to limit BRD.Read moreRead less